CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells
2015 · Scientific Reports · 327 citations
https://doi.org/10.1038/srep11483
A
Aaron Victor
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
660
Citations
8
h-index
8
i10-index
Aaron Victor is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Angiogenesis and VEGF in Cancer & Immune Cell Function and Interaction & T-cell and B-cell Immunology. The author has an h-index of 8, co-authored 19 publications.
ORCID: 0000-0003-4118-3088Papers by this author
worksIL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB
2017 · The Journal of Immunology · 95 citations
https://doi.org/10.4049/jimmunol.1601554
Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
2023 · Cardiovascular Research · 46 citations
https://doi.org/10.1093/cvr/cvad082
1393 Molecular Pathology Data is Heavily Siloed. How Our Institution Used AI to Make Patient Solid Tumor and Myeloid Next-Generation Sequencing Data Available to Clinical Researchers
2025 · Laboratory Investigation · 0 citations
https://doi.org/10.1016/j.labinv.2024.103631
1565 Deep Tissue Learning of EGFR-sensitivity mutant Lung Adenocarcinoma Predicts Duration of Response to Osimertinib
2025 · Laboratory Investigation · 0 citations
https://doi.org/10.1016/j.labinv.2024.103807
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat